These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31197873)

  • 1. Genomic expertise in action: molecular tumour boards and decision-making in precision oncology.
    Bourret P; Cambrosio A
    Sociol Health Illn; 2019 Nov; 41(8):1568-1584. PubMed ID: 31197873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular tumour boards - current and future considerations for precision oncology.
    Tsimberidou AM; Kahle M; Vo HH; Baysal MA; Johnson A; Meric-Bernstam F
    Nat Rev Clin Oncol; 2023 Dec; 20(12):843-863. PubMed ID: 37845306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular screening programs in different countries: what we learned and perspectives.
    Borcoman E; Le Tourneau C; Kamal M
    Curr Opin Oncol; 2019 Sep; 31(5):445-453. PubMed ID: 31261171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience.
    Repetto M; Crimini E; Boscolo Bielo L; Guerini-Rocco E; Ascione L; Bonfanti A; Zanzottera C; Mazzarella L; Ranghiero A; Belli C; Criscitiello C; Esposito A; Barberis MCP; Curigliano G
    Eur J Cancer; 2023 Apr; 183():79-89. PubMed ID: 36801623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing multidisciplinary tumor boards in oncology: a narrative review.
    Mano MS; Çitaku FT; Barach P
    Future Oncol; 2022 Jan; 18(3):375-384. PubMed ID: 34787482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of virtual molecular tumor boards for informed clinical decision-making.
    Angel M; Demiray M; Dişel U; Passos J
    Oncologist; 2024 Jul; 29(7):554-559. PubMed ID: 38761380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.
    Perera-Bel J; Hutter B; Heining C; Bleckmann A; Fröhlich M; Fröhling S; Glimm H; Brors B; Beißbarth T
    Genome Med; 2018 Mar; 10(1):18. PubMed ID: 29544535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular tumor board: a tool for the governance of precision oncology in the real world.
    Incorvaia L; Russo A; Cinieri S
    Tumori; 2022 Aug; 108(4):288-290. PubMed ID: 34918610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision Oncology Core Data Model to Support Clinical Genomics Decision Making.
    Botsis T; Murray JC; Ghanem P; Balan A; Kernagis A; Hardart K; He T; Spiker J; Kreimeyer K; Tao J; Baras AS; Yegnasubramanian S; Canzoniero J; Anagnostou V;
    JCO Clin Cancer Inform; 2023 Apr; 7():e2200108. PubMed ID: 37040583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision-Making in Multidisciplinary Tumor Boards in Breast Cancer Care - An Observational Study.
    Schellenberger B; Diekmann A; Heuser C; Gambashidze N; Ernstmann N; Ansmann L
    J Multidiscip Healthc; 2021; 14():1275-1284. PubMed ID: 34103928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Treatment Decisions in Multidisciplinary Oncology Meetings: A Quantitative Observational Study.
    Soukup T; Lamb BW; Sarkar S; Arora S; Shah S; Darzi A; Green JS; Sevdalis N
    Ann Surg Oncol; 2016 Dec; 23(13):4410-4417. PubMed ID: 27380047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations.
    Koopman B; Groen HJM; Ligtenberg MJL; Grünberg K; Monkhorst K; de Langen AJ; Boelens MC; Paats MS; von der Thüsen JH; Dinjens WNM; Solleveld N; van Wezel T; Gelderblom H; Hendriks LE; Speel EM; Theunissen TE; Kroeze LI; Mehra N; Piet B; van der Wekken AJ; Ter Elst A; Timens W; Willems SM; Meijers RWJ; de Leng WWJ; van Lindert ASR; Radonic T; Hashemi SMS; Heideman DAM; Schuuring E; van Kempen LC
    Oncologist; 2021 Aug; 26(8):e1347-e1358. PubMed ID: 33111480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient attrition in Molecular Tumour Boards: a systematic review.
    Frost H; Graham DM; Carter L; O'Regan P; Landers D; Freitas A
    Br J Cancer; 2022 Nov; 127(8):1557-1564. PubMed ID: 35941175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision medicine in oncology: New practice models and roles for oncology pharmacists.
    Walko C; Kiel PJ; Kolesar J
    Am J Health Syst Pharm; 2016 Dec; 73(23):1935-1942. PubMed ID: 27864201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing a clinical cutting-edge and decision-making activity: an ethnographic teamwork approach to a molecular tumorboard.
    Bot N; Waelli M
    BMC Health Serv Res; 2020 Oct; 20(1):922. PubMed ID: 33028316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidisciplinary tumor boards and their analyses: the yin and yang of outcome measures.
    Engelhardt M; Ihorst G; Schumacher M; Rassner M; Gengenbach L; Möller M; Shoumariyeh K; Neubauer J; Farthmann J; Herget G; Wäsch R
    BMC Cancer; 2021 Feb; 21(1):173. PubMed ID: 33596881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision-making as discovery: Vetting clinical research in a leading precision oncology service.
    Cambrosio A; Campbell J; Drilon AE; Keating P; Polk JB
    Sociol Health Illn; 2024 Mar; 46(3):495-513. PubMed ID: 37796533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of Precision Oncology in Clinical Practice: Results of a National Survey for Health Care Professionals.
    Fasola G; Barducci MC; Pelizzari G; Grossi F; Pinto C; Daniele B; Giordano M; Ortega C; Silva RR; Tozzi VD; Cavanna L; Aprile G
    Oncologist; 2023 Jun; 28(6):e324-e330. PubMed ID: 36848261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practice and Impact of Multidisciplinary Tumor Boards on Patient Management: A Prospective Study.
    Charara RN; Kreidieh FY; Farhat RA; Al-Feghali KA; Khoury KE; Haydar A; Nassar L; Berjawi G; Shamseddine A; El Saghir NS
    J Glob Oncol; 2017 Jun; 3(3):242-249. PubMed ID: 28717766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMBAR - Interactive Alteration annotations for molecular tumor boards.
    Fürstberger A; Ikonomi N; Kestler AMR; Marienfeld R; Schwab JD; Kuhn P; Seufferlein T; Kestler HA
    Comput Methods Programs Biomed; 2023 Oct; 240():107697. PubMed ID: 37441893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.